Navigation Links
SomaLogic Inc. receives Grand Challenges tuberculosis biomarkers grant
Date:2/9/2012

Boulder CO SomaLogic, Inc., announced today that it will receive a tuberculosis (TB) biomarkers grant through the Bill & Melinda Gates Foundation's Grand Challenges in Global Health program, an initiative that seeks to overcome persistent bottlenecks in creating new tools that can radically improve health in the developing world. Urs Ochsner, head of the Infectious Diseases Research Group at SomaLogic, will pursue an innovative research project to identify and validate TB biomarkers, titled "SOMAmer-based detection of tuberculosis biomarkers."

The Grand Challenges TB Biomarkers program provides funding for groundbreaking research into TB biomarkers for the development of a low-cost, simple to use tool that can quickly and accurately diagnose TB in developing countries.

"There is an urgent need to break through barriers in biomarker research in order to develop a highly-sensitive point-of-care diagnostic to improve identification of active TB cases," said Chris Wilson, Director of Global Health Discovery at the Bill & Melinda Gates Foundation. "We hope these innovative ideas lead to effective and affordable TB diagnostics that can make an impact on one of the world's deadliest infectious diseases."

Dr. Ochsner's project is one of ten Grand Challenges TB biomarkers grants announced today. "The initial applications of our SOMAscan proteomic technology to detect certain protein biomarkers of the tuberculosis bacteria have been highly promising and exciting," said Dr. Ochsner. "We are both delighted and grateful to the Gates Foundation for their recognition of the potential of this work, and for their support in helping us bring it to the point where it can make a difference in literally millions of lives."

The most beneficial diagnostic TB test would need to measure both multiple TB bacterial proteins as well as the host proteins involved in the onset and progression of the disease. In addition, it must perform effectively in the conditions in the parts of the world where TB is most often rampant. SomaLogic's breakthrough proteomic technology, based on protein-detecting reagents called "SOMAmers," provides clear advantages over current reagents and methods used in TB tests in terms of accuracy, sensitivity, stability (e.g., no need for refrigeration), ease of production and cost: In short, all of the attributes necessary to develop a POC diagnostic device for remote and resource-poor areas of the world.

In line with the Gates Foundation's Global Access policy, SomaLogic is committed to ensuring that the knowledge gained during this project is promptly and broadly disseminated, and that diagnostic tests that come from this work will be made available and accessible at a reasonable cost to the developing world.


'/>"/>

Contact: Fintan Steele, Ph.D.
fsteele@somalogic.com
720‑214‑3080
SomaLogic, Inc.
Source:Eurekalert

Related biology news :

1. SomaLogic and Ambergen announce agreement for commercial applications of photocleavable biotin
2. SomaLogic announces agreement with leading global pharma company to accelerate R&D
3. SomaLogic and New England Biolabs announce agreement to use SOMAmers for multiple PCR products
4. SomaLogic researchers describe revolutionary new approach to protein analysis and application to early diagnosis of lung cancer
5. St. Josephs receives Canadas first whole-body PET/MRI scanner
6. Rensselaer Professor Ryan Gilbert receives NSF CAREER award
7. WHOIs John Waterbury receives NAS Gilbert Morgan Smith Medal
8. SUNY Downstate receives grant from research to prevent blindness
9. Startup receives $4 million to develop drug delivery targeted to the back of the eye
10. University of Texas chemist receives major grant to improve detection of drug-resistant tuberculosis
11. Kessler Foundation neuroscientist Jordan Grafman receives Humboldt Research Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...
(Date:3/31/2016)... , March 31, 2016 ... ) ("LegacyXChange" or the "Company") LegacyXChange is ... users of its soon to be launched online site ... https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide potential shareholders ... of DNA technology to an industry that is notorious ...
Breaking Biology News(10 mins):
(Date:5/23/2016)... San Antonio, Texas (PRWEB) , ... May 23, 2016 , ... The need for blood ... infographic released this week by the South Texas Blood & Tissue Center, blood donations are ... more than 30 years, and they are down 21 percent in South Texas in the ...
(Date:5/23/2016)... Carolina (PRWEB) , ... May 23, 2016 , ... ... and building management solutions and services based in Aurora, Ohio, has broken ground ... established business in the Research Triangle Park area, this new location solidifies a ...
(Date:5/20/2016)... ... May 20, 2016 , ... Korean researchers say Manumycin A triggers apoptosis, ... new way to treat the disease. Surviving Mesothelioma has just posted an article on ... several Korean institutions based their mesothelioma study on the fact the Manumycin A, a ...
(Date:5/19/2016)... ... May 19, 2016 , ... KCAS Bioanalytical ... Abu Siddiqui as Director, Large Molecule & Biomarker Bioanalysis. , Dr. Siddiqui has ... biomarker discovery studies for preclinical and clinical safety programs. “We’ve seen significant demand ...
Breaking Biology Technology: